全文获取类型
收费全文 | 2667篇 |
免费 | 243篇 |
国内免费 | 53篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 27篇 |
妇产科学 | 6篇 |
基础医学 | 299篇 |
口腔科学 | 18篇 |
临床医学 | 276篇 |
内科学 | 159篇 |
皮肤病学 | 6篇 |
神经病学 | 905篇 |
特种医学 | 64篇 |
外科学 | 794篇 |
综合类 | 148篇 |
预防医学 | 21篇 |
眼科学 | 3篇 |
药学 | 198篇 |
中国医学 | 16篇 |
肿瘤学 | 5篇 |
出版年
2024年 | 4篇 |
2023年 | 37篇 |
2022年 | 48篇 |
2021年 | 78篇 |
2020年 | 113篇 |
2019年 | 87篇 |
2018年 | 103篇 |
2017年 | 82篇 |
2016年 | 84篇 |
2015年 | 66篇 |
2014年 | 109篇 |
2013年 | 156篇 |
2012年 | 96篇 |
2011年 | 98篇 |
2010年 | 89篇 |
2009年 | 68篇 |
2008年 | 75篇 |
2007年 | 92篇 |
2006年 | 82篇 |
2005年 | 62篇 |
2004年 | 70篇 |
2003年 | 63篇 |
2002年 | 66篇 |
2001年 | 55篇 |
2000年 | 53篇 |
1999年 | 42篇 |
1998年 | 57篇 |
1997年 | 65篇 |
1996年 | 52篇 |
1995年 | 83篇 |
1994年 | 58篇 |
1993年 | 67篇 |
1992年 | 63篇 |
1991年 | 61篇 |
1990年 | 31篇 |
1989年 | 54篇 |
1988年 | 44篇 |
1987年 | 41篇 |
1986年 | 46篇 |
1985年 | 51篇 |
1984年 | 59篇 |
1983年 | 34篇 |
1982年 | 34篇 |
1981年 | 32篇 |
1980年 | 21篇 |
1979年 | 9篇 |
1978年 | 5篇 |
1977年 | 7篇 |
1976年 | 8篇 |
1974年 | 2篇 |
排序方式: 共有2963条查询结果,搜索用时 203 毫秒
1.
2.
Intubating conditions after vecuronium and atracurium given in divided doses (the priming technique)
R. K. Mirakhur G. G. La Very F. M. Gibson R. S. J. Clarke 《Acta anaesthesiologica Scandinavica》1986,30(5):347-350
Intubating conditions have been assessed at 60 s following administration of vecuronium 0.1 mg kg-1 or atracurium 0.5 mg kg-1 given either as a single dose after induction of anaesthesia with thiopentone or in divided doses; vecuronium 0.015 mg kg-1 followed 4 or 6 min later by 0.085 mg kg-1, or atracurium 0.075 mg kg-1 followed 4 or 6 min later by 0.425 mg kg-1. In the divided dose groups the smaller initial (priming) dose was given prior to induction of anaesthesia. Onset and duration of clinical relaxation were assessed using a peripheral nerve stimulator. The intubating conditions at 60 s improved significantly, with the use of relaxants in divided doses being acceptable in 80 and 70% of patients, respectively, with vecuronium and atracurium, but the conditions are not as good as those commonly found using suxamethonium. Priming at 6 min has no advantage over priming at 4 min. The onset of complete block was accelerated with priming, but the difference was not significant. The duration of clinical relaxation of vecuronium was significantly prolonged by giving it in divided doses. Unpleasant awareness of muscle weakness was observed in 15 patients, requiring early induction of anaesthesia in five of them. 相似文献
3.
Murali Pagala N. V. Nandakumar S. A. T. Venkatachari Kadirimangalam Ravindran Bellamakonda Amaladevi Tatsuji Namba David Grob 《Muscle & nerve》1993,16(9):911-921
Fatigue mechanisms in normal intercostal muscle and muscle from patients with myasthenia gravis (MG) were evaluated by monitoring the compound muscle action potential (CMAP) and tetanic tension responses to repetitive nerve or muscle stimulation in vitro. When fatigue was induced by nerve stimulation at 30 Hz for 0.5 s every 2.5 s, about half of the original tension decreased after 30 min in normal muscle and 5 min in MG muscle. Analysis of the changes in area of CMAPs and tension indicated that impairment of neuromuscular transmission, muscle membrane excitation, and excitation-contraction (E-C) coupling and contractility accounted for 40%, 29%, and 31% of fatigue in normal muscle, and 83%, 0%, and 17% of fatigue in MG muscle. When fatigue was induced by muscle stimulation at 30 Hz, tension declined by a quarter after 30 min in normal muscle, but by a half after 17 min in MG muscle. Impairment of muscle membrane excitation and E-C coupling and contractility accounted for 58% and 42% of fatigue in normal muscle, and 22% and 78% of fatigue in MG muscle. Thus, fatigue of normal muscle is caused by impairment of at least four processes, and enhanced fatigue of MG muscle is caused by greater impairment of neuromuscular transmission, E-C coupling, and contractility. © 1993 John Wiley & Sons, Inc. 相似文献
4.
To define the underlying mechanism of neuromuscular transmission failure induced by anticholinesterases, we simultaneously performed surface recordings of compound muscle action potentials (CMAPs) and intracellular recordings of miniature end-plate potentials (MEPPs), miniature end-plate current (MEPCs), and end-plate potential (EPPs) in rat diaphragms exposed in vitro to 1 × 10?4 to 2 × 10?2 mmol/L neostigmine methylsulfate. At low concentrations of neostigmine, repetitive stimulation of the phrenic nerve resulted in decrement followed by complete recuperation of CMAP amplitudes. This bimodal pattern was associated with maximal end-plate depolarization at the beginning of the stimulation period, increased MEPP amplitudes, and prolonged time constants of MEPC decays. Higher concentrations of neostigmine resulted in a unimodal decline of amplitudes of CMAPs and EPPS, reduced MEPP amplitudes, and a double exponential time course of MEPC decays. These results indicate that low concentrations of anticholinesterases impaired neuromuscular transmission by producing transient depolarization of the end-plate region. Higher concentrations induced desensitization and direct blockade of the end-plate receptor channel, probably in its open conformation. © 1993 John Wiley & Soncs, Inc. 相似文献
5.
6.
The bradycardia produced by 1 microgram acetylcholine in the isolated perfused rabbit heart, in the presence of vecuronium and atracurium, was studied and compared with control. Vecuronium at a concentration of 2.5 micrograms/litre and atracurium 6 micrograms/litre did not enhance the negative chronotropic effect of acetylcholine. Atracurium produced a statistically significant inhibition of the negative chronotropic effect of acetylcholine. 相似文献
7.
A. C. T. Huizinga R. H. G. Vandenbrom J. M. K. H. Wierda M.D. Ph.D. F. D. M. Hommes P. J. Hennis 《Acta anaesthesiologica Scandinavica》1992,36(5):463-468
The intubating conditions and neuromuscular blocking profile following 600 micrograms.kg-1 rocuronium (Org 9426) have been investigated in patients under various experimental conditions. They were compared with conditions following 1.5 mg.kg-1 suxamethonium, preceded by a precurarising dose (10 mg) of gallamine, and with those in a control group in the absence of a muscle relaxant. Rocuronium produced good to excellent intubating conditions at 60 as well as at 90 s after administration, even though there was only a partial blockade of the adductor pollicis muscle. Intubating conditions following suxamethonium were comparable with those after rocuronium. Half of the control patients could be intubated. The clinical duration and the recovery time of 600 micrograms.kg-1 of rocuronium were 24(4) and 9(3) min (mean(s.d.)), respectively. Rocuronium may have a major advantage over existing non-depolarising muscle relaxants due to the early presence of excellent intubating conditions. The results indicate that rocuronium may replace suxamethonium in procedures in which rapid sequence induction is required. 相似文献
8.
G. Th. H. Van Kempen Dr. P. C. Molenaar 《Journal of neural transmission (Vienna, Austria : 1996)》1992,87(3):193-197
Summary Clinical evidence suggests that endocrinal factors are involved in fluctuations of the symptoms of women with myasthenia gravis. We studied the effect of estradiol and progesterone in an animal model for myasthenia gravis in rats. Although it was found that the mass of muscles was dependent on sex, and in female rats affected by estradiol, the number of acetylcholine receptors in these muscles was independent of sex and hormone administration. Sex hormones failed to influence the severity of muscle weakness in myasthenic rats. 相似文献
9.
The influence of different levels of enflurane anaesthesia on infusion requirements of vecuronium was studied in 40 adult surgical patients. Ninety percent neuromuscular block was maintained by computer controlled infusion of vecuronium. During the first 90 min study period all patients received fentanyl-nitrous oxide-oxygen (2:1) anaesthesia. For the following 90 min the patients were randomly assigned to receive enflurane at different end-tidal concentrations: group I, control, fentanyl-nitrous oxide anaesthesia; group II, enflurane 0.3%-nitrous oxide; group III, enflurane 0.6%-nitrous oxide; group IV, enflurane 0.9%-nitrous oxide. Every patient served as his/her own control and the changes of vecuronium infusion requirements were determined individually. When the administration of enflurane was started, vecuronium infusion requirements decreased progressively until 90 min. In group II the infusion rate lowered from 80±28 to 56±20 μg . kg-1 . h -1 , in group III from 61 ±29 to 34±17 μg . kg-1 . h-1 and in group IV from 65±20 to 30± 14 μg . kg-1 . h-1 . In the control group the infusion rate decreased during the three hour study period from 69± 17 (first 90 min period) to 59± 16 μg . kg-1 . h-1 (second 90 min period). Enflurane reduces the dose requirements of vecuronium administered by continuous infusion in a dose- and time-dependent manner. 相似文献
10.
NISHAN GOUDSOUZIAN 《Paediatric anaesthesia》1997,7(3):183-190
Mivacurium is the only available short-acting nondepolarizing muscle relaxant in clinical use. It is a bis-quaternary benzylisoquinolinium ester hydrolysed by plasma-cholinesterase into inactive compounds. The ED50 and ED95 in children are about 50 μg·kg?1 and 90 μg·kg?1 respectively. In infants, they have a tendency to be lower. A standard intubating dose of 0.25 mg·kg?1 causes complete neuromuscular depression in 1.5–2 min, recovery to 5% in 6–10 min, and complete recovery in 15–20 min. The recent tendency is to use 0.3 mg·kg?1 to obtain better intubating conditions with slight prolongation of effect. Since the recovery profile of mivacurium is independent of the dose and duration, it is most suitable for administration by continuous infusion. The infusion requirement in children is 10–16 μg·kg?1 min?1, which is about twice that of adults. Cutaneous flushes from histamine release are commonly seen with the larger doses of mivacurium; however, the associated hypotensive effects are minimal and counteracted by the tracheal intubation. The duration of action of mivacurium is prolonged in patients with cholinesterase deficiency. Mivacurium's neuromuscular effects can be satisfactorily antagonized by edrophonium or neostigmine. 相似文献